For citations:
Kuzmin O.B., Belyanin V.V., Buchneva N.V., Zhezha V.V., Landar L.N., Stolbova M.V. New drugs for the treatment of resistant hypertension: nonsteroidal mineralcorticoid receptor antagonist finerenone and aldosterone synthase inhibitor baxdrostat. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2024;30(4):364-372. (In Russ.) https://doi.org/10.18705/1607-419X-2024-2393. EDN: XKFDMC